BridgeBio Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2017
Revenue	218.6	9.3	77.65	69.72	8.25	40.56	Upgrade
Revenue Growth (YoY)	181.05%	-88.02%	11.38%	745.14%	-79.66%	-	Upgrade
Cost of Revenue	2.39	2.45	3.43	3.11	0	2.5	Upgrade
Gross Profit	216.2	6.86	74.21	66.6	8.25	38.06	Upgrade
Selling, General & Admin	185.29	150.59	143.19	192.21	145.68	94.35	Upgrade
Research & Development	503.82	455.71	399.46	451.02	337.05	209.95	Upgrade
Other Operating Expenses	-1.53	7.93	43.77	0	0	0	Upgrade
Operating Expenses	687.59	614.23	586.42	643.23	482.73	304.3	Upgrade
Operating Income	-471.38	-607.37	-512.2	-576.63	-474.48	-266.24	Upgrade
Interest Expense / Income	84.64	81.29	80.44	46.78	36.66	8.77	Upgrade
Other Expense / Income	-17.76	-45.46	-111.46	-60.87	-62.41	-14.42	Upgrade
Pretax Income	-538.26	-643.2	-481.18	-562.54	-448.72	-260.59	Upgrade
Net Income	-538.26	-643.2	-481.18	-562.54	-448.72	-260.59	Upgrade
Shares Outstanding (Basic)	179	163	147	144	118	105	Upgrade
Shares Outstanding (Diluted)	179	163	147	144	118	105	Upgrade
Shares Change	17.07%	10.39%	2.16%	22.34%	12.27%	70.15%	Upgrade
EPS (Basic)	-3.22	-3.95	-3.26	-3.90	-3.80	-2.48	Upgrade
EPS (Diluted)	-3.22	-3.95	-3.26	-3.90	-3.80	-2.48	Upgrade
Free Cash Flow	-604.92	-529.03	-314.32	-511.18	-407.23	-256.23	Upgrade
Free Cash Flow Per Share	-3.38	-3.25	-2.13	-3.54	-3.45	-2.44	Upgrade
Gross Margin	98.91%	73.71%	95.58%	95.53%	100.00%	93.84%	Upgrade
Operating Margin	-215.64%	-6528.75%	-659.65%	-827.12%	-5751.99%	-656.41%	Upgrade
Profit Margin	-246.23%	-6913.92%	-619.70%	-806.90%	-5439.74%	-642.47%	Upgrade
Free Cash Flow Margin	-276.73%	-5686.62%	-404.79%	-733.23%	-4936.74%	-631.72%	Upgrade
EBITDA	-443.1	-551.39	-388.8	-504.31	-407.53	-250.96	Upgrade
EBITDA Margin	-202.70%	-5926.98%	-500.72%	-723.37%	-4940.30%	-618.75%	Upgrade
Depreciation & Amortization	10.53	10.53	11.94	11.45	4.54	0.86	Upgrade
EBIT	-453.62	-561.91	-400.75	-515.76	-412.07	-251.82	Upgrade
EBIT Margin	-207.52%	-6040.13%	-516.10%	-739.80%	-4995.38%	-620.86%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).